Skip to main content
Caplight Logo









NanoMosaic

NanoMosaic

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://nanomosaicllc.com/

Last Round

Series A

Dec 6, 2021

Total Funding Raised

$40.75M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

NanoMosaic is a biotechnology company that develops advanced analytical platforms for multiomic biomarker detection, gene therapy manufacturing, and molecular profiling.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Quality Management

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

adeno-associated virusAAVnanoneedle technologygene therapy analyticsbioprocess analyticsquality controlanalytical platformbiotech instrumentationviral vector characterizationadvanced manufacturing technologyAMTlab automationbiopharma QCprocess analytical technologyPAT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NanoMosaic Comparables

Compare NanoMosaic with similar companies based on industry and business-model similarity.

NanoMosaic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Abselion
84%
Refeyn
80%
ProteoWise
78%

NanoMosaic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 6, 2021
SeedApr 2, 2020

Key People

Founding team and executive leadership

Qimin Quan

Chief Scientific Officer Co-Founder

Founding Team

Philippe M.

Chief Executive Officer

Executive Team

NanoMosaic Investors

Notable investors and investment history

NanoMosaic investors
InvestorRounds
RA Capital ManagementSeries A
Time BioVenturesSeries A
Tiger Gene L.L.C.Series A, Seed
Insight PartnersSeries A
Pura Vida InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 497% MoM, reaching 3.8K.

  • May 11, 2026

    Will attend the American Society of Gene & Cell Therapy Annual Meeting in Boston.

NanoMosaic Filings

Explore SEC and related filing metadata, where available.

NanoMosaic filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NanoMosaic's valuation, stock price, and market status.

Is NanoMosaic a public or private company?

NanoMosaic is a private company.

What is the current stock price of NanoMosaic?

NanoMosaic is a private company with no public stock price. No recent secondary market data is available.

How much is NanoMosaic worth (valuation)?

Valuation information for NanoMosaic is not publicly available.

Can I buy NanoMosaic stock?

NanoMosaic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NanoMosaic's last funding round?

NanoMosaic's most recent funding round was Series A on December 6, 2021.

Who are the main investors in NanoMosaic?

Key investors in NanoMosaic include RA Capital Management.

Will NanoMosaic IPO soon?

No public IPO plans have been announced for NanoMosaic.

How can I track NanoMosaic secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NanoMosaic's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range14
Year Founded2017
Last FundingDec 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?